Effects of Caffeine Citrate on Body Mass and Inflammation Levels in Premature Infants

Liu Dong; Chen Li; Xu Yanzhen; Yan Xudong; Huang Jinjie; Yu Jialin; Li Zhiguang

doi:10.13407/j.cnki.jpp.1672.108X.2020.12.006

您当前的位置：

首页 >

文章列表页 >

Effects of Caffeine Citrate on Body Mass and Inflammation Levels in Premature Infants

更新时间：2022-11-03

- Effects of Caffeine Citrate on Body Mass and Inflammation Levels in Premature Infants
- Vol. 26, Issue 12, Pages: 18-21(2020)
- 作者机构：
  
  1. 深圳市人民医院,广东,深圳,518020
  2. 深圳大学总医院,广东,深圳,518060
- 作者简介：
- 基金信息：
- DOI：10.13407/j.cnki.jpp.1672.108X.2020.12.006
  CLC：
- Published：2020，
  
  Published Online：10 December 2020，
扫描看全文
Liu Dong, Chen Li, Xu Yanzhen, et al. Effects of Caffeine Citrate on Body Mass and Inflammation Levels in Premature Infants. [J]. 26(12):18-21(2020)
DOI：

Liu Dong, Chen Li, Xu Yanzhen, et al. Effects of Caffeine Citrate on Body Mass and Inflammation Levels in Premature Infants. [J]. 26(12):18-21(2020) DOI： 10.13407/j.cnki.jpp.1672.108X.2020.12.006.

摘要

目的：研究枸橼酸咖啡因对早产儿体质量及炎症水平的影响。方法：采用回顾性研究方法，选取深圳市人民医院新生儿科使用枸橼酸咖啡因的患儿，与未使用枸橼酸咖啡因病例匹配对照，比较两组患儿生后体质量及炎症水平的变化。结果：本研究共纳入使用枸橼酸咖啡因的患儿及未使用枸橼酸咖啡因患儿各27例。枸橼酸咖啡因组患儿出生体质量恢复时间（15.9±3.6）d，未使用枸橼酸咖啡因组患儿出生体质量恢复时间（10.2±3.6）d，两组比较差异有统计学意义（P<0.01）。枸橼酸咖啡因组患儿生后第7、10、14、18、21、25、28、32天的体质量均明显降低，而第4天及第33~35天两组患儿体质量比较差异无统计学意义。两组患儿各时间段白细胞水平比较差异无统计学意义。生后第19~21天枸橼酸咖啡因组患儿超敏C反应蛋白（hs-CRP）水平0.22 mg/L，未使用枸橼酸咖啡因组患儿hs-CRP水平0.10 mg/L，差异有统计学意义（P<0.05）；余第1、7、14、28 d的hs-CRP水平比较差异无统计学意义（P>0.05）。结论：枸橼酸咖啡因的使用对早产儿早期体质量增长有显著影响，表现为恢复出生体质量时间延长及体质量增长迟缓。对此类早产儿需十分注意其营养管理，保证其体质量平稳增长。

Abstract

Objective: To study the effects of caffeine citrate on body mass and inflammation levels in premature infants. Methods: Retrospective analysis was adopted

case-matched control was used to compare the postnatal mass and inflammation levels of two groups of children (with and without caffeine citrate) in neonates of Shenzhen People’s Hospital. Results: In this study

a total of 27 cases were included in the caffeine citrate group and 27 cases were included in the no caffeine citrate group. The recovery time of body mass in the caffeine citrate group was (15.9±3.6) d

while that of the the no caffeine citrate group was (10.2±3.6) d

with statistically significant difference between two groups (P<0.01). The body mass in the caffeine citrate group decreased significantly on the 7th

10th

14th

18th

21st

25th

28th and 32nd day after birth

while there was no significant difference in body mass between two groups on the 4th day and from the 33rd to 35th day. There was no statistically significant difference in the levels of white blood cells between two groups at various time periods. On the 19th to 21st day after birth

the hypersensitivity C-reactive protein (hs-CRP) level of children in the caffeine citrate group was 0.22 mg/L

and the hs-CRP level in the no caffeine citrate group was 0.10 mg/L

the difference was statistically significant (P<0.05). There was no statistically significant difference in hs-CRP level on the 1st

7th

14th

and 28th day (P>0.05). Conclusion: The use of caffeine citrate has a significant effect on the body mass gain of premature infants in the early stage

which is manifested as prolonged recovery time of birth body mass and slow body mass gain. Attention should be paid to nutrition management for premature infants to ensure the steady body mass gain.

关键词

枸橼酸咖啡因早产儿体质量炎症

Keywords

citrate caffeinepremature infantsbody massnflammation

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Meta-Analysis of Efficacy and Safety of Different Drug Administration Routes for the Treatment of Premature Infants with Patent Ductus Arteriosus

Systematically Review on Effect of Caffeine at Different Starting Times on Prevention and Treatment of Apnea in Very Low Birth Weight Preterm Infants

Pharmacodynamics Study of Chongcao Qingfei Capsule on Chronic Bronchitis in Rats

A Case of Premature Infant with Cholestasis Induced by Drugs

Rationality Analysis of Neonatal Parenteral Nutrition Prescription in Our Hospital

Related Author

Hua Ziyu

Sun Jian

Shen Yue

Xiang Lingling

Yin Huan

Zhang Yong

Chen Wenchao

Lei Jufang

Related Institution

Children’ s Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics

Huangshi Maternal and Child Health Hospital, Edong Medical Group

The People’ s Hospital of Suzhou New District,Jiangsu Suzhou

Suzhou Science and Technology Town Hospital, Jiangsu Suzhou

Shanghai Children’s Hospital, Children’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

⁰